Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem

The antiretroviral drug lopinavir/ritonavir has been recently repurposed for the treatment of COVID-19. Its empirical use has been associated with multiple cardiac adverse reactions pertaining to its ancillary multi-channel blocking properties, vaguely characterized until now. We aimed to characteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Fresse, Audrey, Viard, Delphine, Romani, Serena, Gérard, Alexandre, Lepelley, Marion, Rocher, Fanny, Salem, Joe-Elie, Drici, Milou-Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566676/
https://www.ncbi.nlm.nih.gov/pubmed/33075384
http://dx.doi.org/10.1016/j.ijcard.2020.10.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566676/
https://www.ncbi.nlm.nih.gov/pubmed/33075384
http://dx.doi.org/10.1016/j.ijcard.2020.10.028

Ejemplares similares